Results     31-May-23
Announcements
Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
Sales rise 22.74% to Rs 284.70 crore
Net profit of Astrazeneca Pharma India declined 38.28% to Rs 17.27 crore in the quarter ended March 2023 as against Rs 27.98 crore during the previous quarter ended March 2022. Sales rose 22.74% to Rs 284.70 crore in the quarter ended March 2023 as against Rs 231.96 crore during the previous quarter ended March 2022.

For the full year,net profit rose 61.21% to Rs 99.29 crore in the year ended March 2023 as against Rs 61.59 crore during the previous year ended March 2022. Sales rose 24.50% to Rs 1002.97 crore in the year ended March 2023 as against Rs 805.60 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales284.70231.96 23 1002.97805.60 25
OPM %21.0216.36 -15.8610.70 -
PBDT67.7641.43 64 184.5999.98 85
PBT63.5137.02 72 174.3383.03 110
NP17.2727.98 -38 99.2961.59 61

Previous News
  Astrazeneca Pharma India standalone net profit declines 46.08% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:42 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 03-Nov-21   16:58 )
  Board of Astrazeneca Pharma India recommends Final Dividend
 ( Corporate News - 28-May-22   10:09 )
  Astrazeneca Pharma India to discuss results
 ( Corporate News - 08-Aug-23   11:05 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 19-May-21   09:45 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 11-Aug-20   09:31 )
  Astrazeneca Pharma India receives Import and Market permission for Osimertinib Tablet
 ( Corporate News - 09-Aug-18   10:47 )
  Vivimed Labs Ltd Spikes 12.07%
 ( Hot Pursuit - 07-Feb-19   09:30 )
  Astrazeneca Pharma India reports net profit of Rs 1.52 crore in the December 2013 quarter
 ( Results - Announcements 10-Feb-14   08:15 )
  Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
 ( Results - Announcements 28-May-24   07:37 )
  Astrazeneca Pharma India net profit rises 35.16% in the September 2010 quarter
 ( Results - Announcements 27-Oct-10   16:58 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top